Volume | 626,328 |
|
|||||
News | - | ||||||
Day High | 26.88 | Low High |
|||||
Day Low | 25.57 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
26.25 | 25.57 | 26.88 | 25.98 | 26.32 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
9,956 | 626,328 | US$ 26.04 | US$ 16,307,609 | - | 17.52 - 43.81 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:52:55 | formt | 937 | US$ 25.98 | USD |
Arcturus Therapeutics (ARCT) Options Flow Summary
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
699.8M | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 32.28 | 32.30 | 25.57 | 28.52 | 525,658 | -6.30 | -19.52% |
1 Month | 33.04 | 35.675 | 25.57 | 31.53 | 543,643 | -7.06 | -21.37% |
3 Months | 32.89 | 43.81 | 25.57 | 35.08 | 490,772 | -6.91 | -21.01% |
6 Months | 21.50 | 43.81 | 17.52 | 30.43 | 451,474 | 4.48 | 20.84% |
1 Year | 27.48 | 43.81 | 17.52 | 29.72 | 433,069 | -1.50 | -5.46% |
3 Years | 40.38 | 64.9735 | 11.70 | 29.20 | 538,706 | -14.40 | -35.66% |
5 Years | 7.48 | 129.71 | 5.70 | 39.14 | 556,472 | 18.50 | 247.33% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |